Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cortes

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Oncogene|August 9, 2007
Quantitative monitoring by polymerase colony assay of known mutations resistant to ABL kinase inhibitorsV Nardi, T Raz, X Cao, et al.
The Science of the Total Environment|January 17, 2025
Concentrations and origins of ultrafine particles at a major European harborS Ridolfo, X Querol, A Karanasiou, et al.
Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Evaluation of altered cell-cell communication between glia and neurons in the hippocampus of 3xTg-AD mice at two time pointsTabea M Soelter, Timothy C Howton, Elizabeth J Wilk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2018
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Leukemia|April 11, 2008
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignanciesA Quintás-Cardama, W Tong, T Manshouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 7, 2017
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Oncogene|August 9, 2007
Quantitative monitoring by polymerase colony assay of known mutations resistant to ABL kinase inhibitorsV Nardi, T Raz, X Cao, et al.
The Science of the Total Environment|January 17, 2025
Concentrations and origins of ultrafine particles at a major European harborS Ridolfo, X Querol, A Karanasiou, et al.
Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Evaluation of altered cell-cell communication between glia and neurons in the hippocampus of 3xTg-AD mice at two time pointsTabea M Soelter, Timothy C Howton, Elizabeth J Wilk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2018
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Leukemia|April 11, 2008
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignanciesA Quintás-Cardama, W Tong, T Manshouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 7, 2017
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.
Pageof 31